Home  
  Our Team  
  Patient Info  
  Services  
   
  Pay My Bill  
  Contact Us  

News for Healthier Living

Phase 1 BAFF CAR T clinical trial for patients with relapsed and refractory multiple myeloma underway at UH Seidman Cancer Center

University Hospitals (UH) Seidman Cancer Center hematologist-oncologist Leland Metheny, MD, is leading the trial. He says in the two years since the foundational pre-clinical work was completed, the team has shown that it's feasible to manufacture BAFF CAR T-cells for human subjects.

August 15, 2024


March 30 2026

March 29 2026

March 28 2026

March 27 2026

March 26 2026

March 25 2026

March 24 2026

March 23 2026

March 22 2026

March 21 2026

March 20 2026

March 19 2026

March 18 2026

March 17 2026

March 16 2026